Litigation Details for Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd. (D. Del. 2024)
✉ Email this page to a colleague
Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd. (D. Del. 2024)
| Docket | ⤷ Sign Up | Date Filed | 2024-01-03 |
| Court | District Court, D. Delaware | Date Terminated | 2024-09-03 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory B. Williams |
| Jury Demand | Defendant | Referred To | |
| Parties | ALEXION PHARMA INTERNATIONAL OPERATIONS LTD. | ||
| Patents | 9,447,176; 9,718,880; 9,732,149 | ||
| Attorneys | Gerald J. Flattmann , Jr. | ||
| Firms | Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd. (D. Del. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2024-01-03 | 1 | Complaint | the ’504 patent”), 10,590,189 (“the ’189 patent”), 10,703,809 (“the ’809 patent”), and 9,447,176 (“the … United States Patent Nos. 9,732,149 (“the ’149 patent”), 9,718,880 (“the ’880 patent”), 9,725,504 (“…the ’176 patent”) (collectively, “the Asserted Patents”). ME1 47283720v.1 Case 1:24-cv-00005…economic rights to the Asserted Patents via an exclusive license to patents and applications owned by API… 10. This action for patent infringement arises under the patent laws of the United States, Title | External link to document |
| 2024-01-03 | 3 | Patent/Trademark Report to Commissioner of Patents | 9,725,504; 10,590,189; 10,703,809; 9,447,176. (Attachments: # 1 Patent/Trademark Report)(mpb) (Entered: … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,732,149; 9,718,880… 3 January 2024 1:24-cv-00005 830 Patent Defendant District Court, D. Delaware | External link to document |
| 2024-05-06 | 57 | 1 - Terminate Deadlines and Hearings AND Order - Memorandum and Order | 1 of U.S. Patent No. 9,447,176 ("the '176 patent") and claim 1 of U.S. Patent No. 10,590,189…x27;189 patent") (collectively, the "PI Claims"). Claim 1 of the '189 patent recites…inter partes review (IPR) of the ' 189 patent. Toe Patent Trial and Appeal Board ("PTAB"…Bioepis Co. Ltd. ("Samsung") alleging patent infringement under the Biologics Price Competition…PageID #: 9320 Alexion has asserted six patents and seeks injunctive relief due to the infringement | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
